Oral chemotherapy is becoming increasingly common in treatment of various malignancies. Although oral oncolytics are extremely beneficial for patients, they also present unique challenges for patients and providers alike. Implementing oral chemotherapy often requires a multidisciplinary approach. This lecture discusses several considerations for oral chemotherapy such as prescribing, patient education, adherence, medication access, cost and insurance authorization, monitoring, supportive care, and more. We will walk through a patient case to highlight practical suggestions for successful implementation of oral chemotherapy for patients.

Jose Gaston Guillem, MD, MPH, MBA, will describe how at UNC Medical Center a team of experts carefully reviews each individual patient during a Weekly GI Tumor Board and collaboratively develop a treatment plan which defines the specific timing and sequence of care for each patient.

Jethro Hu, MD, will review the rationale and current evidence supporting the potential role of a ketogenic diet for brain tumor patients, focusing on a recently completed phase 1 safety and feasibility trial.

Anne W. Beaven, MD, will review recent updates and evolving standard of care for management of Hodgkin and Non-Hodgkin lymphoma.